Sort
35,931 grants matching “parkinsons”
Molecular and anatomical characterization of cell types in the aging mouse brain
$1,191,386Hongkui Zeng · Allen Institute · R01 · FY2020 · AG
Fluorescence Microscopy
$1,190,169James W Putney · National Institute Of Environmental Health Sciences · ZIC · FY2015 · ES
Mitochrondrial Etiologies of Parkinsons Disease
$1,190,157James Pepper Bennett · University Of Virginia · P50 · FY2008 · NS
Mitochrondrial Etiologies of Parkinsons Disease
$1,190,125George F Wooten · University Of Virginia · P50 · FY2007 · NS
University of Maryland Claude D. Pepper Older Americans Independence Center (OAIC)
$1,190,048Jay Steven Magaziner · University Of Maryland Baltimore · P30 · FY2022 · AG
Discovery of Rare Variants and Mutations in Parkinson Disease
$1,189,916Jeffery M. Vance · University Of Miami School Of Medicine · P50 · FY2010 · NS
Genome wide SNP analysis in Parkinson's disease
$1,189,490Andrew Singleton · National Institute On Aging · ZIA · FY2023 · AG
ICH Recovery Grant
$1,188,670Daniel Woo · University Of Cincinnati · R01 · FY2017 · NS
THE GENETICS OF PARKINSONISM
$1,187,783Duke University · P50 · FY2001 · NS
The Neuroscience of Everyday World- A novel wearable system for continuous measurement of brain function
$1,187,723David A Boas · Boston University (Charles River Campus) · U01 · FY2023 · EB
RESOLVING THE CRITICAL ROLE OF PINK1 EXPRESSION AND ACTIVITY IN PARKINSON'S DISEASE PATHOPHYSIOLOGY AND THERAPEUTIC INTERVENTION
$1,186,914Mayo Clinic Jacksonville (A Nonprofit Corporation) · · FY2025 · Defense Health Agency
Restoration of Dopaminergic Function in Parkinson's Disease
$1,186,700Greg A. Gerhardt · University Of Kentucky · P50 · FY2006 · NS
Restoration of Dopaminergic Function in Parkinson's Disease
$1,186,609Greg A. Gerhardt · University Of Kentucky · P50 · FY2007 · NS
THERAPEUTIC RESOLUTION OF INFLAMMATION AND NEUROTOXICITY AT THE GUT-BRAIN AXIS FOR DISEASE MODIFICATION IN PARKINSON'S DISEASE
$1,186,151Queensland University Of Technology · · FY2022 · Defense Health Agency
Apoptosis In Neurodegenerative Disorders
$1,185,744Mark P Mattson · National Institute On Aging · Z01 · FY2008 · AG
Leveraging Existing Aging Research Networks to investigate TBI and AD/ADRD risk (LEARN TBI & AD)
$1,185,575Kristen Dams-O'Connor · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · AG
Driving Medical Projects (4 of 4)
$1,185,500Edward Mark Scolnick · Broad Institute, Inc. · RL1 · FY2009 · GM
Neurostimulation of the Nucleus Basalis of Meynert for the cognitive-motor syndrome in Parkinson's disease
$1,185,457Helen Bronte-Stewart · Stanford University · UH3 · FY2024 · NS
Coordination and Statistics for CoQ10 in PD in Phase 3
$1,184,711David Oakes · University Of Rochester · U01 · FY2007 · NS
Coenzyme Q10 in Huntington's Disease
$1,184,326Merit E Cudkowicz · Massachusetts General Hospital · U01 · FY2008 · NS
CLINICAL-GRADE SPINAL CORD NEUROPROSTHESIS TO ALLEVIATE LOCOMOTOR DEFICITS IN PEOPLE WITH PARKINSON'S DISEASE
$1,184,252Centre Hospitalier Universitaire Vaudois (Chuv) · · FY2025 · Defense Health Agency
In Vitro and In Vivo Characterization of Alpha-Synuclein PET Radiotracers
$1,183,686Robert H Mach · University Of Pennsylvania · U19 · FY2025 · NS
Molecular Roles of Cdk5 in Neuronal Functions and Pain Signaling
$1,183,074Ashok Kulkarni · National Institute Of Dental & Craniofacial Research · ZIA · FY2014 · DE
Subcellular RNA-Proteome Mapping in Subtype- and Circuit-Specific Growth Cones: Development, Cell Biology, Disease, and Regeneration
$1,183,000Jeffrey D Macklis · Harvard University · DP1 · FY2018 · NS
Subcellular RNA-Proteome Mapping in Subtype- and Circuit-Specific Growth Cones: Development, Cell Biology, Disease, and Regeneration
$1,183,000Jeffrey D Macklis · Harvard University · DP1 · FY2019 · NS